When to Stop Biologics in Systemic JIA?January 1, 1970Systemic onset juvenile idiopathic arthritis (sJIA) is a dramatic onset inflammatory condition marked by…View Resource JAK Inhibitors in Refractory Adult and Childhood-Onset Still’s DiseaseJanuary 1, 1970Still’s disease is an autoinflammatory disease characterized by spiking fever, rash, polyarthralgia, sore throat…View Resource Still’s Disease Following COVID-19 VaccinationJanuary 1, 1970Both systemic onset juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease are acquired autoinflammatory…View Resource Canakinumab Use in Periodic Febrile DisordersJanuary 1, 1970A retrospective records review of patients with periodic fever syndromes (PFS) receiving IL-1 inhibitor…View Resource 12
JAK Inhibitors in Refractory Adult and Childhood-Onset Still’s DiseaseJanuary 1, 1970Still’s disease is an autoinflammatory disease characterized by spiking fever, rash, polyarthralgia, sore throat…View Resource Still’s Disease Following COVID-19 VaccinationJanuary 1, 1970Both systemic onset juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease are acquired autoinflammatory…View Resource Canakinumab Use in Periodic Febrile DisordersJanuary 1, 1970A retrospective records review of patients with periodic fever syndromes (PFS) receiving IL-1 inhibitor…View Resource 12
Still’s Disease Following COVID-19 VaccinationJanuary 1, 1970Both systemic onset juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease are acquired autoinflammatory…View Resource Canakinumab Use in Periodic Febrile DisordersJanuary 1, 1970A retrospective records review of patients with periodic fever syndromes (PFS) receiving IL-1 inhibitor…View Resource 12
Canakinumab Use in Periodic Febrile DisordersJanuary 1, 1970A retrospective records review of patients with periodic fever syndromes (PFS) receiving IL-1 inhibitor…View Resource